With the MDR sprint mercifully behind them, medtech firms must now turn their attention to the next leg of Europe’s revamped regulatory relay: the IVDR.
Affordability, increasing needs from an aging world, and almost unlimited access to the internet in developed parts of the world are the drivers of change.